Literature DB >> 23180987

What patients and providers should understand about economic evaluations in oncology.

Jonas A de Souza1, Gilberto de Lima Lopes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23180987      PMCID： PMC3396819          DOI： 10.1200/JOP.2012.000612

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  7 in total

Review 1.  An introduction to Markov modelling for economic evaluation.

Authors:  A Briggs; M Sculpher
Journal:  Pharmacoeconomics       Date:  1998-04       Impact factor: 4.981

2.  NICE rejects drug for metastatic breast cancer because of cost and poor efficacy.

Authors:  Mark Pownall
Journal:  BMJ       Date:  2010-06-11

Review 3.  Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.

Authors:  Scott Ramsey; Richard Willke; Andrew Briggs; Ruth Brown; Martin Buxton; Anita Chawla; John Cook; Henry Glick; Bengt Liljas; Diana Petitti; Shelby Reed
Journal:  Value Health       Date:  2005 Sep-Oct       Impact factor: 5.725

4.  Information on cost-effectiveness: an essential product of a national comparative effectiveness program.

Authors: 
Journal:  Ann Intern Med       Date:  2008-05-15       Impact factor: 25.391

5.  Economic analysis and clinical trials.

Authors:  M F Drummond; G L Stoddart
Journal:  Control Clin Trials       Date:  1984-06

6.  Cost-benefit analysis.

Authors:  R Robinson
Journal:  BMJ       Date:  1993-10-09

7.  Proposal for a novel methodology to screen and score cost versus survival for anticancer drugs in metastatic disease: could cost weigh in evaluation?

Authors:  Helmy M Guirgis
Journal:  J Oncol Pract       Date:  2012-07       Impact factor: 3.840
  7 in total
  1 in total

1.  End-of-Life Health-Care Cost of Patients With Lung Cancer: A Retrospective Study.

Authors:  Kyriakos Souliotis; Chara Kani; Androniki Marioli; Aggeliki Kamboukou; Aikaterini Prinou; Konstantinos Syrigos; Sophia Markantonis
Journal:  Health Serv Res Manag Epidemiol       Date:  2019-04-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.